InStride Health

InStride Health is a specialty outpatient provider of anxiety and OCD care for children, teenagers and young adults, founded in 2021. The company delivers treatment virtually, on an insurance-based model, and serves patients aged 7-22 across multiple states in America. Its founders previously spent a decade building the anxiety and OCD specialty programme at McLean Hospital. The company's stated aim is to close gaps in access to paediatric mental healthcare by removing months-long waitlists, difficult onboarding and inconsistent application of evidence-based care.

Clinically, the company applies cognitive behavioural therapy (CBT), acceptance and commitment therapy (ACT) and exposure and response prevention (ERP) through research-backed protocols. Treatment is delivered by multidisciplinary care teams comprising therapists, exposure coaches and psychiatrists. A technology-enhanced care model supports real-time contact during and between sessions and underpins outcome tracking; the virtual platform extends the delivery of care to wherever families are.

InStride Health has raised more than $56 million in venture funding and is expanding nationwide. Work sits at the intersection of behavioural health and digital care, spanning telehealth delivery infrastructure, treatment-model tooling and measurement. The organisation describes itself as mission-driven, family-centred and focused on affordability through insurance coverage, with an ambition to become the most trusted provider of paediatric anxiety and OCD treatment in the country.